dailyai.report

OpenAI released GPT-Rosalind, a reasoning model tailored for drug discovery and genomics analysis. The system targets protein reasoning and complex scientific workflows to speed up laboratory research. It moves beyond general-purpose LLMs by integrating domain-specific scientific logic. Researchers can now automate high-dimensional biological data analysis with greater precision and fewer hallucinations.